Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Eli Lilly Corp. buy gerihouse

Start price
€68.59
31.08.17 / 50%
Target price
€80.00
10.11.17
Performance (%)
3.37%
End price
€70.90
10.11.17
Summary
This prediction ended on 10.11.17 with a price of €70.90. With a performance of 3.37%, the BUY prediction by gerihouse for Eli Lilly Corp. closed with a slight gain. gerihouse has a follow-up prediction for Eli Lilly Corp. where he still thinks Eli Lilly Corp. is a Buy. gerihouse has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Eli Lilly Corp. 1.625% 1.625% 131.935% 358.371%
iShares Core DAX® 2.149% 5.415% 21.385% 22.595%
iShares Nasdaq 100 0.838% 1.926% 44.386% 55.330%
iShares Nikkei 225® 1.143% 2.887% 27.641% 9.481%
iShares S&P 500 1.265% 3.698% 33.327% 49.646%

According to gerihouse what are the pros and cons of Eli Lilly Corp. for the foreseeable future?

Pros
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Future proof or reliable business model
Small cyclical dependencies
Well known brand
Revenue growth >5% per year expected
Cons

Comments by gerihouse for this prediction

In the thread Eli Lilly Corp. diskutieren
Prediction Buy
Perf. (%) 3.37%
Target price 80.000
Change
Ends at 10.11.17

Kursücksetzer nutzen


Eli Lilly schüttet seit 1885 eine Dividende aus!
               

Der US-Pharmakonzern Eli Lilly zahlt eine Dividende von 52 US-Cents je Aktie an seine Investoren aus. Auf Jahressicht erhalten die Aktionäre 2,08 US-Dollar. Dies entspricht einer
 aktuellen Dividendenrendite in Höhe von 2,53 Prozent beim derzeitigen
Aktienkurs von 82,34 US-Dollar (Stand: 19. Juni 2017).


Eli Lilly zahlt seit 1885 ununterbrochen eine Dividende an seine
Aktionäre aus. Aktionäre erhalten die nächste Dividendenzahlung am 8.
September 2017 (Record date: 15. August 2017).


Im ersten Quartal 2017 kletterte der Umsatz von Eli Lilly um 7
Prozent im Vergleich zum Vorjahr auf 5,2 Mrd. US-Dollar, wie bereits am
25. April 2017 berichtet wurde. Der Ertrag je Aktie lag bei 0,98
US-Dollar (Vorjahr: 0,83 US-Dollar). Eli Lilly and Company gehört zu den
 größten Pharmaunternehmen weltweit und ist seit über 50 Jahren auch in
Deutschland vertreten. Das Unternehmen mit Firmensitz in Indianapolis
ist 1876 von dem Pharmakologen, Offizier und Unternehmer Eli Lilly in
Indianapolis gegründet worden.


Seit Jahresanfang liegt die Aktie an der Wall Street mit 12,06 Prozent im Plus. Die aktuelle Marktkapitalisierung beträgt 90,77 Mrd. US-Dollar.


Prediction Buy
Perf. (%) 3.37%
Target price 80.000
Change
Ends at 10.11.17

(Vom Mitglied beendet)

Current prediction by gerihouse for Eli Lilly Corp.

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€546.50
16.11.23
€690.00
16.11.24
32.06%
22:26

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative

Stopped prediction by gerihouse for Eli Lilly Corp.

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€370.05
04.11.22
€610.00
04.11.23
44.17%
05.11.23

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€213.80
18.01.22
€350.00
18.01.23
47.33%
23.09.22

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€173.98
25.01.21
€250.00
25.01.22
23.00%
17.01.22

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€126.32
18.03.20
€150.00
12.10.20
6.54%
12.10.20

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€98.78
13.10.19
€120.00
26.10.19
0.30%
26.10.19

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€104.32
06.09.19
€120.00
13.10.19
-5.58%
13.10.19

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€103.80
24.06.19
€130.79
06.09.19
0.94%
06.09.19

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€102.30
18.04.19
€120.00
24.05.19
3.46%
24.05.19

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€106.63
24.01.19
€126.28
04.04.19
6.26%
04.04.19

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€71.74
10.05.18
€99.22
06.09.18
32.15%
06.09.18

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€71.74
10.11.16
€85.00
18.04.17
8.26%
18.04.17

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€63.10
24.03.16
€90.00
08.08.16
16.05%
08.08.16

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€71.93
13.10.15
€90.20
04.01.16
4.66%
04.01.16

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€65.85
05.05.15
€83.00
22.07.15
19.78%
22.07.15

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€49.89
11.09.14
€60.00
24.11.14
8.90%
24.11.14

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€39.56
09.10.12
€45.00
21.02.13
5.46%
21.02.13

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€34.30
04.07.12
€40.00
05.09.12
8.03%
05.09.12

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative